Eplus Inc: Form 10-K for the period ended Mar 31, 2017
Filed with the SEC on May 25, 2017 and accepted by EDGAR at May 24, 2017, 18:19 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-01-01 to 2017-03-31 | $256.4m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 12 months2016-04-01 to 2017-03-31 | $1.03bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2017-01-01 to 2017-03-31 | $76.4m | us-gaap:GrossProfit |
| Gross profit | 12 months2016-04-01 to 2017-03-31 | $299.8m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2017-01-01 to 2017-03-31 | $55.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 12 months2016-04-01 to 2017-03-31 | $205.2m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2017-01-01 to 2017-03-31 | $18.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2016-04-01 to 2017-03-31 | $85.7m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-01-01 to 2017-03-31 | $8.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 12 months2016-04-01 to 2017-03-31 | $35.6m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-01-01 to 2017-03-31 | $10.5m | us-gaap:NetIncomeLoss |
| Net income | 12 months2016-04-01 to 2017-03-31 | $50.6m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2017-01-01 to 2017-03-31 | $0.75 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2016-04-01 to 2017-03-31 | $3.60 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2017-01-01 to 2017-03-31 | $0.76 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2016-04-01 to 2017-03-31 | $3.65 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2016-04-01 to 2017-03-31 | 14,028,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Dividends paid | 12 months2016-04-01 to 2017-03-31 | $0 | us-gaap:PaymentsOfDividends |
| Share repurchases | 12 months2016-04-01 to 2017-03-31 | $30.5m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2017-03-31 | $109.8m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-03-31 | $597.3m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-03-31 | $741.7m | us-gaap:Assets |
| Current liabilities | At period end2017-03-31 | $376.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-03-31 | $395.8m | us-gaap:Liabilities |
| Shareholders' equity | At period end2017-03-31 | $345.9m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001022408-17-000009. Last ingested by Listed: Nov 6, 2026, 17:13 ET. Listed shows no prices and gives no investment advice.